Check-Cap Ltd. (NASDAQ:CHEK – Get Free Report) saw a significant decline in short interest in the month of August. As of August 31st, there was short interest totalling 65,600 shares, a decline of 11.4% from the August 15th total of 74,000 shares. Based on an average daily trading volume, of 10,700 shares, the days-to-cover ratio is currently 6.1 days. Currently, 1.5% of the company’s shares are short sold.
Check-Cap Stock Down 1.1 %
Shares of NASDAQ CHEK traded down $0.02 on Wednesday, reaching $1.73. 18,718 shares of the company’s stock traded hands, compared to its average volume of 98,681. Check-Cap has a 12 month low of $1.64 and a 12 month high of $4.63. The business’s 50 day simple moving average is $1.92 and its two-hundred day simple moving average is $2.11. The company has a market cap of $10.12 million, a price-to-earnings ratio of -0.58 and a beta of 0.39.
Wall Street Analysts Forecast Growth
Separately, StockNews.com started coverage on shares of Check-Cap in a report on Saturday. They issued a “sell” rating on the stock.
Check-Cap Company Profile
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.
Recommended Stories
- Five stocks we like better than Check-Cap
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- How Much Can You Make in Stocks in One Month?
- Using the MarketBeat Dividend Yield Calculator
- This Is the Top Large-Cap Stock Insiders Are Buying
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.